Chiral Quest
Chiral Quest (Suzhou) Co., Ltd. (凯瑞斯德生化(苏州)有限公司) is a Chinese pharmaceutical CDMO specializing in chiral chemistry. The company operates asymmetric catalytic hydrogenation, enzyme-catalyzed biosynthesis, flow chemistry, and process innovation technology platforms, using proprietary catalysts to develop and manufacture chiral drug molecules, key raw materials, regulatory starting materials (RSMs), and advanced GMP intermediates for global pharmaceutical companies. Founded around its asymmetric hydrogenation catalyst technology, Chiral Quest merged with Jiangxi Longlai in 2012 and with Suzhou Pengxu in 2020; the group employs more than 800 people including a research team of roughly 150. Suzhou is the parent company and R&D center, Jiangxi Longlai is the manufacturing base, and the company maintains offices in the United Kingdom and the United States. Chiral Quest is a brochure-site company with no public API, developer portal, or machine-readable data surface.
Chiral Quest is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Pharmaceuticals, Chemistry, and Chiral Chemistry.
Chiral Quest’s developer surface includes product news and 8 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Company 4
The organization behind the API
Other 2
Properties that don't map to a standard resource type